These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 29032922)

  • 21. Seasonal difference in brain serotonin transporter binding predicts symptom severity in patients with seasonal affective disorder.
    Mc Mahon B; Andersen SB; Madsen MK; Hjordt LV; Hageman I; Dam H; Svarer C; da Cunha-Bang S; Baaré W; Madsen J; Hasholt L; Holst K; Frokjaer VG; Knudsen GM
    Brain; 2016 May; 139(Pt 5):1605-14. PubMed ID: 26994750
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Brain serotonin transporter binding in non-depressed patients with Parkinson's disease.
    Guttman M; Boileau I; Warsh J; Saint-Cyr JA; Ginovart N; McCluskey T; Houle S; Wilson A; Mundo E; Rusjan P; Meyer J; Kish SJ
    Eur J Neurol; 2007 May; 14(5):523-8. PubMed ID: 17437611
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Overlapping expression of serotonin transporters and neurokinin-1 receptors in posttraumatic stress disorder: a multi-tracer PET study.
    Frick A; Åhs F; Palmquist ÅM; Pissiota A; Wallenquist U; Fernandez M; Jonasson M; Appel L; Frans Ö; Lubberink M; Furmark T; von Knorring L; Fredrikson M
    Mol Psychiatry; 2016 Oct; 21(10):1400-7. PubMed ID: 26619809
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serotonin and dopamine transporter PET changes in the premotor phase of LRRK2 parkinsonism: cross-sectional studies.
    Wile DJ; Agarwal PA; Schulzer M; Mak E; Dinelle K; Shahinfard E; Vafai N; Hasegawa K; Zhang J; McKenzie J; Neilson N; Strongosky A; Uitti RJ; Guttman M; Zabetian CP; Ding YS; Adam M; Aasly J; Wszolek ZK; Farrer M; Sossi V; Stoessl AJ
    Lancet Neurol; 2017 May; 16(5):351-359. PubMed ID: 28336296
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A nonlinear relationship between cerebral serotonin transporter and 5-HT(2A) receptor binding: an in vivo molecular imaging study in humans.
    Erritzoe D; Holst K; Frokjaer VG; Licht CL; Kalbitzer J; Nielsen FA; Svarer C; Madsen J; Knudsen G
    J Neurosci; 2010 Mar; 30(9):3391-7. PubMed ID: 20203198
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Binge eating disorder and morbid obesity are associated with lowered mu-opioid receptor availability in the brain.
    Joutsa J; Karlsson HK; Majuri J; Nuutila P; Helin S; Kaasinen V; Nummenmaa L
    Psychiatry Res Neuroimaging; 2018 Jun; 276():41-45. PubMed ID: 29655552
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Seasonality-resilient individuals downregulate their cerebral 5-HT transporter binding in winter - A longitudinal combined
    Mc Mahon B; Nørgaard M; Svarer C; Andersen SB; Madsen MK; Baaré WFC; Madsen J; Frokjaer VG; Knudsen GM
    Eur Neuropsychopharmacol; 2018 Oct; 28(10):1151-1160. PubMed ID: 30077433
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Simple and rapid quantification of serotonin transporter binding using [
    Gryglewski G; Rischka L; Philippe C; Hahn A; James GM; Klebermass E; Hienert M; Silberbauer L; Vanicek T; Kautzky A; Berroterán-Infante N; Nics L; Traub-Weidinger T; Mitterhauser M; Wadsak W; Hacker M; Kasper S; Lanzenberger R
    Neuroimage; 2017 Apr; 149():23-32. PubMed ID: 28119137
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of FlipIDAM as a SERT-selective SPECT imaging agent.
    Lemoine L; Lieberman BP; Ploessl K; Zheng P; Kung HF
    Nucl Med Biol; 2013 Oct; 40(7):879-86. PubMed ID: 23856117
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Measurement of serotonin transporter binding with PET and [11C]MADAM: a test-retest reproducibility study.
    Lundberg J; Halldin C; Farde L
    Synapse; 2006 Sep; 60(3):256-63. PubMed ID: 16752362
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High-resolution PET imaging reveals subtle impairment of the serotonin transporter in an early non-depressed Parkinson's disease cohort.
    Fazio P; Ferreira D; Svenningsson P; Halldin C; Farde L; Westman E; Varrone A
    Eur J Nucl Med Mol Imaging; 2020 Sep; 47(10):2407-2416. PubMed ID: 32020370
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of estrogen and testosterone treatment on serotonin transporter binding in the brain of surgically postmenopausal women--a PET study.
    Jovanovic H; Kocoska-Maras L; Rådestad AF; Halldin C; Borg J; Hirschberg AL; Nordström AL
    Neuroimage; 2015 Feb; 106():47-54. PubMed ID: 25462800
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serotonin Synthesis and Reuptake in Social Anxiety Disorder: A Positron Emission Tomography Study.
    Frick A; Åhs F; Engman J; Jonasson M; Alaie I; Björkstrand J; Frans Ö; Faria V; Linnman C; Appel L; Wahlstedt K; Lubberink M; Fredrikson M; Furmark T
    JAMA Psychiatry; 2015 Aug; 72(8):794-802. PubMed ID: 26083190
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Incongruent reduction of serotonin transporter associated with suicide attempts in patients with major depressive disorder: a positron emission tomography study with 4-[18F]-ADAM.
    Yeh YW; Ho PS; Chen CY; Kuo SC; Liang CS; Ma KH; Shiue CY; Huang WS; Cheng CY; Wang TY; Lu RB; Huang SY
    Int J Neuropsychopharmacol; 2014 Oct; 18(3):. PubMed ID: 25522405
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cerebral serotonin transporter binding is inversely related to body mass index.
    Erritzoe D; Frokjaer VG; Haahr MT; Kalbitzer J; Svarer C; Holst KK; Hansen DL; Jernigan TL; Lehel S; Knudsen GM
    Neuroimage; 2010 Aug; 52(1):284-9. PubMed ID: 20382236
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quantitative PET studies of the serotonin transporter in MDMA users and controls using [11C]McN5652 and [11C]DASB.
    McCann UD; Szabo Z; Seckin E; Rosenblatt P; Mathews WB; Ravert HT; Dannals RF; Ricaurte GA
    Neuropsychopharmacology; 2005 Sep; 30(9):1741-50. PubMed ID: 15841106
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An exploratory study of clinical measures associated with subsyndromal pathological gambling in patients with binge eating disorder.
    Yip SW; White MA; Grilo CM; Potenza MN
    J Gambl Stud; 2011 Jun; 27(2):257-70. PubMed ID: 20577790
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of serum BDNF levels on central serotonin transporter availability in obese versus non-obese adults: A [(11)C]DASB positron emission tomography study.
    Hinderberger P; Rullmann M; Drabe M; Luthardt J; Becker GA; Blüher M; Regenthal R; Sabri O; Hesse S
    Neuropharmacology; 2016 Nov; 110(Pt A):530-536. PubMed ID: 27108933
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Brain serotonin and dopamine transporter bindings in adults with high-functioning autism.
    Nakamura K; Sekine Y; Ouchi Y; Tsujii M; Yoshikawa E; Futatsubashi M; Tsuchiya KJ; Sugihara G; Iwata Y; Suzuki K; Matsuzaki H; Suda S; Sugiyama T; Takei N; Mori N
    Arch Gen Psychiatry; 2010 Jan; 67(1):59-68. PubMed ID: 20048223
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Suicidal ideation modulates the reduction in serotonin transporter availability in male military conscripts with major depression: A 4-[18F]-ADAM PET study.
    Yeh YW; Ho PS; Chen CY; Kuo SC; Liang CS; Yen CH; Huang CC; Shiue CY; Huang WS; Ma KH; Lu RB; Huang SY
    World J Biol Psychiatry; 2015 Oct; 16(7):502-12. PubMed ID: 26068129
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.